IP Verse

Reddie & Grose patent opposition analysis

The comprehensive analysis of Reddie & Grose opposition landscape, with a particular emphasis on intellectual property (IP) dynamics.

Stay updated with the latest patent oppositions filed by Reddie & Grose

Patent Number	Title	Applicant	Opposition Date	Opposition Company
EP3756650	Formulations Of (+)-2-[1-(3-Ethoxy-4-Methoxy-Phenyl)-2-Methanesulfonyl-Ethyl]-4-Acetyl Aminoisoindoline-1,3-Dione	AMGEN EUROPE	Oct 24, 2025	CAMULON
EP3539540	Pharmaceutical Composition, Methods For Treating And Uses Thereof	BOEHRINGER INGELHEIM	Sep 15, 2025	CAMULON
EP4056056	Atomizer And Electronic Cigarette Comprising The Same	SHENZHEN EIGATE TECHNOLOGY	Sep 10, 2025	PHILIP MORRIS
EP3411021	New Use Of A Combination Of Sacubitril And Valsartan	NOVARTIS	Sep 1, 2025	CAMULON
EP4208054	Cartomizer For An Aerosol Generating Device With Leakage Prevention	JAPAN TOBACCO	Aug 6, 2025	PHILIP MORRIS
EP4258905	Aerosol Generating Material	NICOVENTURES	Aug 6, 2025	PHILIP MORRIS
EP4321157	New Use Of A Combination Of An Angiotensin Receptor Blocker (Arb) With A Neutral Endopeptidase Inhibitor (Nepi)	NOVARTIS	Jul 21, 2025	CAMULON
EP3226841	Anticancer Compositions	ARAGON PHARMACEUTICALS	Jul 7, 2025	ZENTIVA KS
EP4175602	Patient Handling Apparatus	ARJO HOLDING AKTIEBOLAG	Jul 2, 2025	BAXTER
EP3570885	Method Of Treating Or Ameliorating Metabolic Disorders Using Glp-1 Receptor Agonists Conjugated To Antagonists For Gastric Inhibitory Peptide Receptor (Gipr)	AMGEN	Jun 17, 2025	CAMULON

Top companies who are the clients of Reddie & Grose